Studies suggest a close association between the occurrence and progression of CRC and the immune escape mediated by the PD-1/PD-L1 signaling pathway, rendering PD-1 and PD-L1 the most sought-after targets in immunotherapy [4]. Here, CD274 is linked to colorectal carcinoma.